Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Apr 13;140(4):1043–1053.e8. doi: 10.1016/j.jaci.2017.03.028

Fig 2.

Fig 2

Percent histamine release from washed basophil-enriched suspensions from omalizumab (blue) and placebo (red) subjects stimulated with the 5 concentrations of milk (0.001, 0.01, 0.11, 10 μg/mL), anti-lgE, or media alone (Spont Med) at baseline (BL) and visits M4, 16, 22, 28, 30, and 32. Statistically significant p-values are indicated in the text.